Correspondence 0001683168-23-009028 from CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc.
Date: Dec. 21, 2023 · CIK: 0001729427 · Accession: 0001683168-23-009028
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275973
Letter
A.G.P. / Alliance Global Partners
590 Madison Ave., 28th Floor
New York, NY 10022
December 21,
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: CNS Pharmaceuticals Inc.
Registration Statement on Form S-1
Filed December 8, 2023
File No: 333-275973
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P / Alliance Global Partners as lead Placement Agent, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00pm Eastern Time on December 26, 2023 or as soon thereafter as practicable.
Very truly yours,
A.G.P / Alliance Global Partners
Show Raw Text
CORRESP
1
filename1.htm
A.G.P. / Alliance Global Partners
590 Madison Ave., 28th Floor
New York, NY 10022
December 21,
2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
CNS Pharmaceuticals Inc.
Registration Statement on Form S-1
Filed December 8, 2023
File No: 333-275973
Ladies and Gentlemen:
Pursuant to Rule 461
promulgated under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P / Alliance Global Partners as
lead Placement Agent, hereby requests acceleration of the effective date of the above-referenced Registration
Statement so that it will become effective at 5:00pm Eastern Time on December 26, 2023 or as soon thereafter as
practicable.
Very truly yours,
A.G.P / Alliance Global Partners
By:
/s/ Thomas J. Higgins
Name:
Thomas J. Higgins
Title:
Managing Director